Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

1/16/2009 Telecon


Submission Type: Original Application Submission ID: 125280/0 Office: OVRR

Japanese Encephalitis Virus Vaccine Inactivated

Intercell AG

Telecon Date/Time: 16-JAN-2009      Initiated by FDA?     Yes
Telephone Number:

Communication Categorie(s): Advice


Telecon Summary: Discussion of revisions to PI provided to Sponsor on January 16, 2008 as well as PMCs. CBER and Sponsor agreed on final wording of PI which will be sent to Sponsor later in the day for approval by Sponsor. Protocol timelines were discussed for PMCs and will be included in the approval letter.

FDA Participants:
Daryll Miller
Richard Daemer
Lew Markoff
Jeff Roberts
Rose Tiernan

Non-FDA Participants:
Paul Wilson
Katrin Dubischar-Kastner
Elisabeth Schuller
Shailesh Dewasthaly

Trans-BLA Group: No

Related STNs: None

Related PMCs: None

Return to Approval History, Letters, Reviews, and Related Documents

Page Last Updated: 09/24/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English